Insulin Syringes Market Research Report Information By Syringe Size (3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml), Others), By Disease (Type 1 Diabetes And Type 2 Diabetes), By End-use (Hospitals & Clinics, Homecare Settings, Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents

1. Executive summary

2. Market Introduction

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. Research Methodology

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. Market Dynamics

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. Market Factor Analysis

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL Insulin Syringes MARKET, BY Syringe Size

6.1. Overview

6.2. 3/10 CC Syringe (0.3ml)

6.3. 1/2 CC Syringe (0.5ml)

6.4. 1CC Syringe (1ml)

6.5. Others

7. GLOBAL Insulin Syringes MARKET, BY Disease

7.1. Overview

7.2. Type 1 Diabetes

7.3. Type 2 Diabetes

8. GLOBAL Insulin Syringes MARKET, BY End User

8.1. Overview

8.2. Hospitals & Clinics

8.3. Homecare Settings

8.4. Others

9. GLOBAL Insulin Syringes MARKET, by Region

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. India

9.4.3. Japan

9.4.4. South Korea

9.4.5. Australia

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. Competitive Landscape

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Insulin Syringes Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Insulin Syringes Market,

10.7. Key developments and Growth Strategies

10.7.1. New Syringe Size Launch/Disease Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. Company ProfileS

11.1. Novo Nordisk A/S

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Syringe Sizes Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Biocon Ltd

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Syringe Sizes Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Abbott Laboratories

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Syringe Sizes Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Terumo Nipro Medical Corporation

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Syringe Sizes Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Cardinal Health Inc

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Syringe Sizes Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. BECKTON AND DICKINSON COMPANY

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Syringe Sizes Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Eli Lilly and Company

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Syringe Sizes Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. IBM Nipro Medical Corporation

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Syringe Sizes Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Medline Industries

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Syringe Sizes Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Hindustan syringe and medical device Ltd.

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Syringe Sizes Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. Appendix

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 Global Insulin Syringes Market, Synopsis, 2018-2032

TABLE 2 Global Insulin Syringes Market, Estimates & Forecast, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 6 North America Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 7 North America Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 8 North America Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 9 North America Insulin Syringes MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 10 U.S. Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 11 U.S. Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 12 U.S. Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 13 Canada Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 14 Canada Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 15 Canada Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 16 Europe Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 17 Europe Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 18 Europe Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 19 Europe Insulin Syringes MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 20 Germany Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 21 Germany Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 22 Germany Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 23 France Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 24 France Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 25 France Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 26 Italy Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 27 Italy Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 28 Italy Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 29 Spain Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 30 Spain Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 31 Spain Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 32 U.K Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 33 U.K Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 34 U.K Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 35 Rest of Europe Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 36 Rest of Europe Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 37 Rest of Europe Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 38 Asia Pacific Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 39 Asia Pacific Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 40 Asia Pacific Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 41 Asia Pacific Insulin Syringes MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 42 Japan Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 43 Japan Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 44 Japan Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 45 China Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 46 China Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 47 China Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 48 India Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 49 India Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 50 India Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 51 Australia Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 52 Australia Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 53 Australia Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 54 south korea Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 55 south korea Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 56 south korea Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 57 Rest of asia-pacific Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 58 Rest of asia-pacific Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 59 Rest of asia-pacific Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 60 Rest of WOrld Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 61 Rest of WOrld Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 62 Rest of WOrld Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 63 Rest of WOrld Insulin Syringes MARKET, BY Country, 2018-2032 (USD BILLION)

TABLE 64 Middle east Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 65 Middle east Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 66 Middle east Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 67 Africa Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 68 Africa Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 69 Africa Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 70 Latin america Insulin Syringes MARKET, BY Syringe Size, 2018-2032 (USD BILLION)

TABLE 71 Latin america Insulin Syringes MARKET, BY DISEASE, 2018-2032 (USD BILLION)

TABLE 72 Latin america Insulin Syringes MARKET, BY END USER, 2018-2032 (USD BILLION)

LIST OF FIGURES

FIGURE 1 Research Process

FIGURE 2 Market Structure for the Global Insulin Syringes Market

FIGURE 3 Market Dynamics for the Global Insulin Syringes Market

FIGURE 4 Global Insulin Syringes Market, Share (%), BY Syringe Size, 2022

FIGURE 5 Global Insulin Syringes Market, Share (%), BY DISEASE, 2022

FIGURE 6 Global Insulin Syringes Market, Share (%), BY END USER, 2022

FIGURE 7 Global Insulin Syringes Market, Share (%), by Region, 2022

FIGURE 8 north AMERICA: Insulin Syringes MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 Europe: Insulin Syringes MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 Asia-Pacific: Insulin Syringes MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 Rest of the world: Insulin Syringes MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 Global Insulin Syringes Market: Company Share Analysis, 2022 (%)

FIGURE 13 Novo Nordisk A/S: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 Novo Nordisk A/S: SWOT ANALYSIS

FIGURE 15 Biocon Ltd: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 Biocon Ltd: SWOT ANALYSIS

FIGURE 17 Abbott Laboratories: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 Abbott Laboratories: SWOT ANALYSIS

FIGURE 19 Terumo Nipro Medical Corporation: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 Terumo Nipro Medical Corporation: SWOT ANALYSIS

FIGURE 21 Cardinal Health Inc.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 Cardinal Health Inc.: SWOT ANALYSIS

FIGURE 23 BECKTON AND DICKINSON COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 BECKTON AND DICKINSON COMPANY: SWOT ANALYSIS

FIGURE 25 Eli Lilly and Company: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 Eli Lilly and Company: SWOT ANALYSIS

FIGURE 27 IBM Nipro Medical Corporation: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 IBM Nipro Medical Corporation: SWOT ANALYSIS

FIGURE 29 Medline Industries: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 Medline Industries: SWOT ANALYSIS

FIGURE 31 Hindustan syringe and medical device Ltd.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 Hindustan syringe and medical device Ltd.: SWOT ANALYSIS